Heartlung Machine Market

Heart-lung Machine Market Size

The global heart-lung machine market was valued at USD 369.8 million in 2024 and is expected to exhibit growth at a CAGR of 4.6% from 2025 to 2034 period. The market growth is attributed to the increasing prevalence of cardiovascular disease, growing number of organ transplant surgeries, contributing to their growing adoption. 

The global burden of cardiovascular diseases has been steadily rising due to factors such as aging populations, sedentary lifestyles, poor dietary habits, and increasing rates of hypertension and diabetes. According to the World Health Organization (WHO), cardiovascular diseases account for approximately 17.9 million deaths annually, representing 32% of all global deaths. These conditions often necessitate surgeries that require the use of heart-lung machines for effective cardiac support, driving the demand for these cardiovascular devices.

A heart-lung machine, also known as a cardiopulmonary bypass (CPB) machine, is a medical device used for open-heart surgeries to temporarily take over the functions of the heart and lungs. The heart-lung machine performs the essential tasks of oxygenating the blood, removing carbon dioxide, and circulating the oxygenated blood back into the patient's body.

Heart-lung Machine Market Trends

Technological advancements in heart-lung machines are a key growth driver for the market, as innovations in design, functionality, and performance continue to enhance the capabilities of these critical devices. These advancements have improved the safety, efficiency, and ease of use of heart-lung machines, making them an essential tool in cardiovascular surgeries and other complex procedures.

• Recent innovations in oxygenator technology have resulted in more efficient and compact devices that provide better oxygenation during surgery. Enhanced blood pump designs have also improved circulation stability and reduced the risk of complications. These advancements have made heart-lung machines more reliable, supporting their increasing adoption in a wide range of surgeries.
  
• Additionally, modern heart-lung machines are equipped with advanced monitoring systems that provide real-time data on patient vitals, blood flow, and oxygenation levels. These systems not only improve surgical precision but also ensure greater patient safety during complex procedures. Automation features have minimized human error, allowing surgeons and healthcare teams to focus on other critical aspects of surgery.
  

Heart-lung Machine Market Analysis

Based on type, the market is segmented as single roller pump and double roller pump. The single roller pump segment is expected to drive business growth and expand at a CAGR of 4.3%, reaching over USD 337 million by 2034.

• Single roller pumps have a long-standing history of reliability in maintaining consistent blood flow during surgeries. Their simple yet effective mechanism ensures stable extracorporeal membrane oxygenation, which is essential in critical procedures requiring prolonged extracorporeal circulation.
  
• Compared to alternative pumping mechanisms, single roller pumps are more cost-effective, making them accessible to a broader range of healthcare facilities, including those in emerging markets. Their affordability does not compromise performance, ensuring their continued dominance in the market.
  

Based on application, the heart-lung machine market is classified into cardiac surgeries, lung surgeries, acute respiratory failure treatment, and other applications. The cardiac surgeries segment dominated the market with a revenue share of 40.4% in 2024.

• As conditions like coronary artery disease, heart failure, and valvular heart disease become more prevalent, the demand for cardiac surgeries rises in tandem. According to the Centers for Disease Control and Prevention (CDC), approximately 20.1 million adults aged 20 and older had coronary artery disease in the U.S. in 2023. Central to addressing these intricate medical challenges are heart-lung machines, solidifying their dominance in the market.
  
• Improved healthcare infrastructure and rising healthcare expenditures, particularly in emerging economies, have enhanced the accessibility of advanced surgical procedures. This development has increased the adoption of heart-lung machines in cardiac surgeries worldwide.
  

Based on end use, the heart-lung machine market is classified into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment dominated the market in 2024 and is anticipated to reach USD 241.4 million by the end of the forecast period.

• Heart-lung machines are crucial in post-transplantation regimens, as they effectively suppress the immune system to prevent the body from rejecting transplanted organs. Their efficacy and reliability make them the first-line choice in immunosuppressive protocols, solidifying their dominance in this segment.
  
• The rising prevalence of end-stage organ failure due to chronic conditions like diabetes, cardiovascular diseases, and liver cirrhosis has led to a surge in organ transplantation rates. This growth directly fuels the demand for heart-lung machine to ensure transplant success and longevity, thereby fueling the market growth.
  

The U.S. heart-lung machine market accounted for USD 139.6 million in 2024 and is anticipated to grow at a CAGR of 3.9% between 2025 to 2034 period.

• The country performs a substantial number of cardiac surgeries annually, including coronary artery bypass grafting (CABG) and valve replacements, which necessitate the use of heart-lung machines.
  
• Favorable reimbursement policies, significant R&D investments, and the presence of key market players further bolster the U.S. leadership in the market.
  

France heart-lung machine market is projected to grow remarkably in the coming years.

• The country is known for its high-quality cardiac surgery centers that perform advanced procedures requiring heart-lung machines. Government-funded healthcare initiatives and favorable insurance coverage encourage the adoption of modern surgical technologies, solidifying France significant market share.
  
• Additionally, ongoing clinical trials and innovations in cardiac care enhance the adoption of heart-lung machines.
  

Japan holds a dominant position in the Asia Pacific heart-lung machine market.

• Cardiovascular diseases are a growing concern in Japan, particularly among the elderly, leading to increased demand for cardiac surgeries. The country’s focus on minimally invasive procedures and adoption of high-precision surgical equipment has further propelled the demand for advanced heart-lung machines. Supportive government policies and high healthcare spending also contribute to Japan market position.
  

Heart-lung Machine Market Share

Several key players in the market are making strides in type innovation and strategic partnerships to maintain market leadership. Companies are investing heavily in R&D to develop advanced heart-lung machines with enhanced features such as real-time monitoring, integration with other surgical equipment, and enhanced biocompatibility. Additionally, partnerships with healthcare providers are being forged to improve type accessibility in emerging markets. Regulatory compliance and adherence to international quality standards are crucial aspects of the strategies employed by these companies to cater to a global market. These developments are helping companies meet the increasing demand for safe and efficient heart-lung machines.

Heart-lung Machine Market Companies

Prominent players operating in the heart-lung machine industry include:

• BRAILE
• Edwards
• ELITE LIFE CARE
• EUROSETS
• FRESENIUS MEDICAL CARE
• GETINGE
• HEART CARE INDIA CO
• hemovent
• Jarvik HEART
• LivaNova
• Medtronic
• NIPRO
• Palex
• Philips
• TERUMO
  

Heart-lung Machine Industry News:

• In March 2023, LivaNova announced that they had received the U.S. FDA 510(k) clearance for their Essenz heart-lung machine intended for cardiopulmonary bypass (CPB) procedures. This machine is incorporated with advanced cable management and components for a smooth user interface and better clinical results. This regulatory approval helped the company to enhance its R&D capabilities and increase its business revenue.
  
• In April 2021, Getinge AB announced the availability of HL 40 heart-lung machines in several countries across Europe. This machine provides controlled circulation of oxygenated blood during complex cardiac surgical interventions. This strategic move helped the company to expand its geographic presence and increase its customer base.
  

The heart-lung machine market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Single roller pump
• Double roller pump

Market, By Application

• Cardiac surgeries
• Lung surgeries
• Acute respiratory failure treatment
• Other applications

Market, By End Use

• Hospitals and clinics
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE